{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:08:46Z","timestamp":1787695726966,"version":"build-2784847793"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270353, 82304935, 82400404"],"award-info":[{"award-number":["82270353, 82304935, 82400404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270353, 82304935, 82400404"],"award-info":[{"award-number":["82270353, 82304935, 82400404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270353, 82304935, 82400404"],"award-info":[{"award-number":["82270353, 82304935, 82400404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Science and Technology Innovation Program for Cultivation of Lightening Stars","award":["Yangfan Project, 23YF1448400"],"award-info":[{"award-number":["Yangfan Project, 23YF1448400"]}]},{"name":"TCM Project of Shanghai Municipal Health Commission","award":["2022QN031"],"award-info":[{"award-number":["2022QN031"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}]},{"name":"Three-year Action Plan for Shanghai TCM Development and Inheritance Program","award":["ZY(2021-2023)-0103"],"award-info":[{"award-number":["ZY(2021-2023)-0103"]}]},{"name":"Organizational Key Research and Development Program of Shanghai University of Traditional Chinese Medicine","award":["2023 YZZ02"],"award-info":[{"award-number":["2023 YZZ02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00709-9","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T14:50:04Z","timestamp":1742309404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation"],"prefix":"10.1186","volume":"23","author":[{"given":"Yufei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaorui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"709_CR1","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/S0735-1097(24)04310-9","volume":"83","author":"B Stark","year":"2024","unstructured":"Stark B, Johnson C, Roth GA. Global prevalence of coronary artery disease: an update from the global burden of disease study. J Am Coll Cardiol. 2024;83:2320\u20132320.","journal-title":"J Am Coll Cardiol"},{"key":"709_CR2","first-page":"785","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova M, Kehrel BE, Corkrey HA, Freedman JE. Thrombosis and platelets: an update. Eur Heart J. 2017;38:785\u201391.","journal-title":"Eur Heart J"},{"key":"709_CR3","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u2013826.","journal-title":"Eur Heart J"},{"key":"709_CR4","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","volume":"322","author":"MD Trip","year":"1990","unstructured":"Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322:1549\u201354.","journal-title":"N Engl J Med"},{"key":"709_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","volume":"16","author":"PEJ van der Meijden","year":"2019","unstructured":"van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16:166\u201379.","journal-title":"Nat Rev Cardiol"},{"key":"709_CR6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jacc.2019.03.531","volume":"74","author":"K Szummer","year":"2019","unstructured":"Szummer K, Jernberg T, Wallentin L. From early Pharmacology to recent Pharmacology interventions in acute coronary syndromes: JACC State-of-the-Art review. J Am Coll Cardiol. 2019;74:1618\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"709_CR7","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","volume":"144","author":"AA Damluji","year":"2021","unstructured":"Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, Cohen MG, Balsam LB, Chikwe J, American Heart Association Council on Clinical C. Mechanical complications of acute myocardial infarction: A scientific statement from the American heart association. Circulation. 2021;144:e16\u201335.","journal-title":"Circulation"},{"key":"709_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","volume":"20","author":"M Gawaz","year":"2023","unstructured":"Gawaz M, Geisler T, Borst O. Current concepts and novel targets for antiplatelet therapy. Nat Rev Cardiol. 2023;20:583\u201399.","journal-title":"Nat Rev Cardiol"},{"key":"709_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.chroma.2005.03.088","volume":"1074","author":"HB Li","year":"2005","unstructured":"Li HB, Chen F. Isolation and purification of Baicalein, Wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr A. 2005;1074:107\u201310.","journal-title":"J Chromatogr A"},{"key":"709_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/np900068t","volume":"72","author":"J Li","year":"2009","unstructured":"Li J, Ding Y, Li XC, Ferreira D, Khan S, Smillie T, Khan IA. Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora. J Nat Prod. 2009;72:983\u20137.","journal-title":"J Nat Prod"},{"key":"709_CR11","first-page":"237","volume":"3","author":"P D\u2019mello","year":"2012","unstructured":"D\u2019mello P, Shetgiri P, Darji K. Investigation and quantitation of phytoconstituents from oroxylum indicum bark by GC-mass and HPLC techniques. Int J Pharm Biol Sci. 2012;3:237\u201342.","journal-title":"Int J Pharm Biol Sci"},{"key":"709_CR12","doi-asserted-by":"crossref","unstructured":"Nian H, Zhang Q, Ma M-H, Zhang Y-J, Wu T-j, Liu J, Fu D-y, Xu L-L, Wang K. Clinical application of Gaofang (Medicated Paste) in cardiovascular disease. Chin Med Cult 2022.","DOI":"10.1097\/MC9.0000000000000029"},{"key":"709_CR13","doi-asserted-by":"publisher","first-page":"e1714","DOI":"10.1038\/cddis.2015.86","volume":"6","author":"L Wei","year":"2015","unstructured":"Wei L, Zhou Y, Qiao C, Ni T, Li Z, You Q, Guo Q, Lu N. Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1alpha destabilization. Cell Death Dis. 2015;6:e1714.","journal-title":"Cell Death Dis"},{"key":"709_CR14","doi-asserted-by":"publisher","first-page":"eabo7868","DOI":"10.1126\/sciadv.abo7868","volume":"9","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang L, Cui J, Wang S, Han Y, Shao H, Wang C, Hu Y, Li X, Zhou Q, et al. Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression. Sci Adv. 2023;9:eabo7868.","journal-title":"Sci Adv"},{"key":"709_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2021.05.018","volume":"515","author":"D Bai","year":"2021","unstructured":"Bai D, Sun T, Zhao J, Du J, Bu X, Cao W, Zhao Y, Lu N. Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota. Cancer Lett. 2021;515:73\u201385.","journal-title":"Cancer Lett"},{"key":"709_CR16","doi-asserted-by":"publisher","first-page":"106590","DOI":"10.1016\/j.phrs.2022.106590","volume":"187","author":"D Zhao","year":"2023","unstructured":"Zhao D, Gao Y, Su Y, Zhou Y, Yang T, Li Y, Wang Y, Sun Y, Chen L, Zhang F, et al. Oroxylin A regulates cGAS DNA hypermethylation induced by methionine metabolism to promote HSC senescence. Pharmacol Res. 2023;187:106590.","journal-title":"Pharmacol Res"},{"key":"709_CR17","doi-asserted-by":"crossref","unstructured":"Ji Y, Han J, Lee N, Yoon JH, Youn K, Ha HJ, Yoon E, Kim DH, Jun M. Neuroprotective effects of Baicalein, Wogonin, and oroxylin A on amyloid Beta-Induced toxicity via NF-kappaB\/MAPK pathway modulation. Molecules 2020, 25.","DOI":"10.3390\/molecules25215087"},{"key":"709_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, Li S, Guo Y, Wei L. CDK9 Inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 2022;18:1879\u201397.","journal-title":"Autophagy"},{"key":"709_CR19","doi-asserted-by":"publisher","first-page":"101392","DOI":"10.1016\/j.redox.2019.101392","volume":"29","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhu Q, Bu X, Zhou Y, Bai D, Guo Q, Gao Y, Lu N. Triggering apoptosis by oroxylin A through caspase-8 activation and p62\/SQSTM1 proteolysis. Redox Biol. 2020;29:101392.","journal-title":"Redox Biol"},{"key":"709_CR20","doi-asserted-by":"publisher","first-page":"705617","DOI":"10.3389\/fphar.2021.705617","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chen L, Li C, Shi H, Wang Q, Yang W, Fang L, Leng Y, Sun W, Li M, et al. Oroxylin a attenuates limb ischemia by promoting angiogenesis via modulation of endothelial cell migration. Front Pharmacol. 2021;12:705617.","journal-title":"Front Pharmacol"},{"key":"709_CR21","doi-asserted-by":"crossref","unstructured":"Jin Y, Tan M, Yin Y, Lin C, Zhao Y, Zhang J, Jiang T, Li H, He M. Oroxylin A alleviates myocardial ischemia-reperfusion injury by quelling ferroptosis via activating the DUSP10\/MAPK-Nrf2 pathway. Phytother Res 2024.","DOI":"10.1002\/ptr.8315"},{"key":"709_CR22","doi-asserted-by":"crossref","unstructured":"Paramesha B, Anwar MS, Meghwani H, Maulik SK, Arava SK, Banerjee SK. Sirt1 and Sirt3 activation improved cardiac function of diabetic rats via modulation of mitochondrial function. Antioxid (Basel) 2021, 10.","DOI":"10.3390\/antiox10030338"},{"key":"709_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.303584","volume":"116","author":"DI Brown","year":"2015","unstructured":"Brown DI, Griendling KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015;116:531\u201349.","journal-title":"Circ Res"},{"key":"709_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Murugesan P, Huang K, Cai H. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol. 2020;17:170\u201394.","journal-title":"Nat Rev Cardiol"},{"key":"709_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jacc.2017.05.043","volume":"70","author":"B Niemann","year":"2017","unstructured":"Niemann B, Rohrbach S, Miller MR, Newby DE, Fuster V, Kovacic JC. Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: part 3 of a 3-Part series. J Am Coll Cardiol. 2017;70:230\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"709_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tips.2024.02.001","volume":"45","author":"MA Beg","year":"2024","unstructured":"Beg MA, Huang M, Vick L, Rao KNS, Zhang J, Chen Y. Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases. Trends Pharmacol Sci. 2024;45:290\u2013303.","journal-title":"Trends Pharmacol Sci"},{"key":"709_CR27","doi-asserted-by":"publisher","first-page":"107413","DOI":"10.1016\/j.pharmthera.2019.107413","volume":"205","author":"DL Clemens","year":"2020","unstructured":"Clemens DL, Duryee MJ, Hall JH, Thiele GM, Mikuls TR, Klassen LW, Zimmerman MC, Anderson DR. Relevance of the antioxidant properties of methotrexate and Doxycycline to their treatment of cardiovascular disease. Pharmacol Ther. 2020;205:107413.","journal-title":"Pharmacol Ther"},{"key":"709_CR28","doi-asserted-by":"publisher","first-page":"33154","DOI":"10.1074\/jbc.M110.143685","volume":"285","author":"JW Zmijewski","year":"2010","unstructured":"Zmijewski JW, Banerjee S, Bae H, Friggeri A, Lazarowski ER, Abraham E. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem. 2010;285:33154\u201364.","journal-title":"J Biol Chem"},{"key":"709_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.122.18756","volume":"79","author":"A Kamynina","year":"2022","unstructured":"Kamynina A, Guttzeit S, Eaton P, Cuello F. Nitroxyl donor CXL-1020 lowers blood pressure by targeting C195 in Cyclic Guanosine-3\u2019,5\u2019-Monophosphate-Dependent protein kinase I. Hypertension. 2022;79:946\u201356.","journal-title":"Hypertension"},{"key":"709_CR30","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.120.048183","volume":"142","author":"JB Goodman","year":"2020","unstructured":"Goodman JB, Qin F, Morgan RJ, Chambers JM, Croteau D, Siwik DA, Hobai I, Panagia M, Luptak I, Bachschmid M, et al. Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload-Induced Myocardial Failure in Mice. Circulation. 2020;142:2459\u201369.","journal-title":"Circulation"},{"key":"709_CR31","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/hh0801.089861","volume":"88","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 2001;88:756\u201362.","journal-title":"Circ Res"},{"key":"709_CR32","doi-asserted-by":"crossref","unstructured":"Masselli E, Pozzi G, Vaccarezza M, Mirandola P, Galli D, Vitale M, Carubbi C, Gobbi G. ROS in platelet biology: functional aspects and methodological insights. Int J Mol Sci 2020, 21.","DOI":"10.3390\/ijms21144866"},{"key":"709_CR33","doi-asserted-by":"publisher","first-page":"13959","DOI":"10.1096\/fj.202001086RRR","volume":"34","author":"D Vara","year":"2020","unstructured":"Vara D, Tarafdar A, Celikag M, Patinha D, Gulacsy CE, Hounslea E, Warren Z, Ferreira B, Koeners MP, Caggiano L, Pula G. NADPH oxidase 1 is a novel Pharmacological target for the development of an antiplatelet drug without bleeding side effects. FASEB J. 2020;34:13959\u201377.","journal-title":"FASEB J"},{"key":"709_CR34","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1093\/eurheartj\/ehac034","volume":"43","author":"Y Chen","year":"2022","unstructured":"Chen Y, Fu W, Zheng Y, Yang J, Liu Y, Qi Z, Wu M, Fan Z, Yin K, Chen Y, et al. Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study. Eur Heart J. 2022;43:3556\u201374.","journal-title":"Eur Heart J"},{"key":"709_CR35","doi-asserted-by":"publisher","first-page":"107378","DOI":"10.1016\/j.vph.2024.107378","volume":"155","author":"J Sharma","year":"2024","unstructured":"Sharma J, Bhargava P, Mishra P, Bhatia J, Arya DS. Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: evidence from in-vitro and in-vivo studies. Vascul Pharmacol. 2024;155:107378.","journal-title":"Vascul Pharmacol"},{"key":"709_CR36","doi-asserted-by":"crossref","unstructured":"Sajeev A, Hegde M, Girisa S, Devanarayanan TN, Alqahtani MS, Abbas M, Sil SK, Sethi G, Chen JT, Kunnumakkara AB. Oroxylin A: A promising flavonoid for prevention and treatment of chronic diseases. Biomolecules 2022, 12.","DOI":"10.3390\/biom12091185"},{"key":"709_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bcp.2014.05.007","volume":"90","author":"Y Wang","year":"2014","unstructured":"Wang Y, Miao H, Li W, Yao J, Sun Y, Li Z, Zhao L, Guo Q. CXCL12\/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562\/ADM cells. Biochem Pharmacol. 2014;90:212\u201325.","journal-title":"Biochem Pharmacol"},{"key":"709_CR38","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1038\/s41401-022-00868-9","volume":"43","author":"HY Yang","year":"2022","unstructured":"Yang HY, Zhang C, Hu L, Liu C, Pan N, Li M, Han H, Zhou Y, Li J, Zhao LY, et al. Platelet CFTR Inhibition enhances arterial thrombosis via increasing intracellular Cl(-) concentration and activation of SGK1 signaling pathway. Acta Pharmacol Sin. 2022;43:2596\u2013608.","journal-title":"Acta Pharmacol Sin"},{"key":"709_CR39","doi-asserted-by":"crossref","unstructured":"Zhang WB, Zheng YF, Wu YG. Protective Effects of Oroxylin A against Doxorubicin-Induced Cardiotoxicity via the Activation of Sirt1 in Mice. Oxid Med Cell Longev 2021, 2021:6610543.","DOI":"10.1155\/2021\/6610543"},{"key":"709_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","volume":"143","author":"Z Qi","year":"2021","unstructured":"Qi Z, Hu L, Zhang J, Yang W, Liu X, Jia D, Yao Z, Chang L, Pan G, Zhong H, et al. PCSK9 (Proprotein convertase subtilisin\/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36. Circulation. 2021;143:45\u201361.","journal-title":"Circulation"},{"key":"709_CR41","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.CIR.91.5.1354","volume":"91","author":"NA Turner","year":"1995","unstructured":"Turner NA, Moake JL, Kamat SG, Schafer AI, Kleiman NS, Jordan R, McIntire LV. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, Heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation. 1995;91:1354\u201362.","journal-title":"Circulation"},{"key":"709_CR42","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1016\/j.actbio.2012.07.013","volume":"8","author":"AB Van de Walle","year":"2012","unstructured":"Van de Walle AB, Fontenot J, Spain TG, Brunski DB, Sanchez ES, Keay JC, Curtis ME, Johnson MB, Snyder TA, Schmidtke DW. The role of fibrinogen spacing and patch size on platelet adhesion under flow. Acta Biomater. 2012;8:4080\u201391.","journal-title":"Acta Biomater"},{"key":"709_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1182\/blood-2014-06-579474","volume":"125","author":"MR Cozzi","year":"2015","unstructured":"Cozzi MR, Guglielmini G, Battiston M, Momi S, Lombardi E, Miller EC, De Zanet D, Mazzucato M, Gresele P, De Marco L. Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. Blood. 2015;125:697\u2013705.","journal-title":"Blood"},{"key":"709_CR44","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1160\/TH11-06-0400","volume":"106","author":"L Hu","year":"2011","unstructured":"Hu L, Fan Z, Du H, Ni R, Zhang S, Yin K, Ye J, Zhang Y, Wei X, Zhang X, et al. BF061, a novel antiplatelet and antithrombotic agent targeting P2Y(1)(2) receptor and phosphodiesterase. Thromb Haemost. 2011;106:1203\u201314.","journal-title":"Thromb Haemost"},{"key":"709_CR45","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1161\/CIRCRESAHA.122.321787","volume":"132","author":"Y Chen","year":"2023","unstructured":"Chen Y, Hong J, Zhong H, Zhao Y, Li J, Shen W, Luo X, Shi H, Hu L, Liu J, Gao W. IL-37 attenuates platelet activation and thrombosis through IL-1R8 pathway. Circ Res. 2023;132:e134\u201350.","journal-title":"Circ Res"},{"key":"709_CR46","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jtha.2023.02.006","volume":"21","author":"L Fang","year":"2023","unstructured":"Fang L, Yu S, Tian X, Fu W, Su L, Chen Z, Yan C, He J, Hong J, Lian W, et al. Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation. J Thromb Haemost. 2023;21:1336\u201351.","journal-title":"J Thromb Haemost"},{"key":"709_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13:120.","journal-title":"J Hematol Oncol"},{"key":"709_CR48","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.114.013743","volume":"131","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhang S, Hu L, Zhai L, Xue R, Ye J, Chen L, Cheng G, Mruk J, Kunapuli SP, Ding Z. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis. Circulation. 2015;131:1160\u201370.","journal-title":"Circulation"},{"key":"709_CR49","doi-asserted-by":"publisher","first-page":"154862","DOI":"10.1016\/j.phymed.2023.154862","volume":"116","author":"Y Tu","year":"2023","unstructured":"Tu Y, Tan L, Tao H, Li Y, Liu H. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. Phytomedicine. 2023;116:154862.","journal-title":"Phytomedicine"},{"key":"709_CR50","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","volume":"12","author":"H Xiao","year":"2022","unstructured":"Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H. Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism. Acta Pharm Sin B. 2022;12:2887\u2013904.","journal-title":"Acta Pharm Sin B"},{"key":"709_CR51","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2018.03.065","volume":"173","author":"L Dai","year":"2018","unstructured":"Dai L, Zhao T, Bisteau X, Sun W, Prabhu N, Lim YT, Sobota RM, Kaldis P, Nordlund P. Modulation of Protein-Interaction States through the cell cycle. Cell. 2018;173:1481\u2013e14941413.","journal-title":"Cell"},{"key":"709_CR52","doi-asserted-by":"crossref","unstructured":"Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the Lactate Dehydrogenase Assay. Cold Spring Harb Protoc 2018, 2018.","DOI":"10.1101\/pdb.prot095497"},{"key":"709_CR53","first-page":"1","volume":"15","author":"AAM Abdallah","year":"2023","unstructured":"Abdallah AAM, Bafail R, Zaman AY, Aldhafiri AJ, Alalawi A, Omran FM, Baghdadi HH, Abdellah WA, Alsharif AM, Al Thagfan SS, et al. Acute Paracetamol toxicity-induced inflammatory and oxidative effects are relieved by Aleppo galls: a novel experimental study. Int J Physiol Pathophysiol Pharmacol. 2023;15:1\u201311.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"709_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/CIRCULATIONAHA.115.015656","volume":"132","author":"SJ Cameron","year":"2015","unstructured":"Cameron SJ, Ture SK, Mickelsen D, Chakrabarti E, Modjeski KL, McNitt S, Seaberry M, Field DJ, Le NT, Abe J, Morrell CN. Platelet extracellular regulated protein kinase 5 is a redox switch and triggers maladaptive platelet responses and myocardial infarct expansion. Circulation. 2015;132:47\u201358.","journal-title":"Circulation"},{"key":"709_CR55","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2017-03-773614","volume":"130","author":"TN Durrant","year":"2017","unstructured":"Durrant TN, van den Bosch MT, Hers I. Integrin \u03b1(IIb)\u03b2(3) outside-in signaling. Blood. 2017;130:1607\u201319.","journal-title":"Blood"},{"key":"709_CR56","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2141.2004.05032.x","volume":"126","author":"P Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 P. P-selectin in haemostasis. Br J Haematol. 2004;126:298\u2013306.","journal-title":"Br J Haematol"},{"key":"709_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.stem.2021.10.009","volume":"29","author":"V Janbandhu","year":"2022","unstructured":"Janbandhu V, Tallapragada V, Patrick R, Li Y, Abeygunawardena D, Humphreys DT, Martin E, Ward AO, Contreras O, Farbehi N, et al. Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction. Cell Stem Cell. 2022;29:281\u2013e297212.","journal-title":"Cell Stem Cell"},{"key":"709_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2009.02.013","volume":"206","author":"CS Tsai","year":"2009","unstructured":"Tsai CS, Loh SH, Liu JC, Lin JW, Chen YL, Chen CH, Cheng TH. Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Atherosclerosis. 2009;206:86\u201394.","journal-title":"Atherosclerosis"},{"key":"709_CR59","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1124\/mol.109.058297","volume":"76","author":"JC Liu","year":"2009","unstructured":"Liu JC, Chen CH, Chen JJ, Cheng TH. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Mol Pharmacol. 2009;76:1186\u201395.","journal-title":"Mol Pharmacol"},{"key":"709_CR60","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1038\/sj.emboj.7600706","volume":"24","author":"J Kwon","year":"2005","unstructured":"Kwon J, Qu CK, Maeng JS, Falahati R, Lee C, Williams MS. Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. EMBO J. 2005;24:2331\u201341.","journal-title":"EMBO J"},{"key":"709_CR61","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1089\/ars.2013.5337","volume":"20","author":"JY Jang","year":"2014","unstructured":"Jang JY, Min JH, Chae YH, Baek JY, Wang SB, Park SJ, Oh GT, Lee SH, Ho YS, Chang TS. Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation. Antioxid Redox Signal. 2014;20:2528\u201340.","journal-title":"Antioxid Redox Signal"},{"key":"709_CR62","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/j.1538-7836.2005.01429.x","volume":"3","author":"SP Watson","year":"2005","unstructured":"Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin AlphaIIb beta3 signaling in platelets. J Thromb Haemost. 2005;3:1752\u201362.","journal-title":"J Thromb Haemost"},{"key":"709_CR63","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","volume":"69","author":"P Hao","year":"2017","unstructured":"Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol. 2017;69:2952\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"709_CR64","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1001\/jama.2023.19524","volume":"330","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li X, Chen G, Xian Y, Zhang H, Wu Y, Yang Y, Wu J, Wang C, He S, et al. Traditional Chinese medicine compound (Tongxinluo) and clinical outcomes of patients with acute myocardial infarction: the CTS-AMI randomized clinical trial. JAMA. 2023;330:1534\u201345.","journal-title":"JAMA"},{"key":"709_CR65","doi-asserted-by":"publisher","first-page":"408187","DOI":"10.1155\/2012\/408187","volume":"2012","author":"CH Liu","year":"2012","unstructured":"Liu CH, Chen MF, Tseng TL, Chen LG, Kuo JS, Lee TJ. Oroxylin A, but not vasopressin, ameliorates cardiac dysfunction of endotoxemic rats. Evid Based Complement Alternat Med. 2012;2012:408187.","journal-title":"Evid Based Complement Alternat Med"},{"key":"709_CR66","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/eurheartj\/ehad362","volume":"44","author":"D Capodanno","year":"2023","unstructured":"Capodanno D, Angiolillo DJ. Personalised antiplatelet therapies for coronary artery disease: what the future holds. Eur Heart J. 2023;44:3059\u201372.","journal-title":"Eur Heart J"},{"key":"709_CR67","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","volume":"389","author":"F Costa","year":"2017","unstructured":"Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025\u201334.","journal-title":"Lancet"},{"key":"709_CR68","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/eurheartj\/ehz593","volume":"41","author":"M Simonsson","year":"2020","unstructured":"Simonsson M, Wallentin L, Alfredsson J, Erlinge D, Hellstrom Angerud K, Hofmann R, Kellerth T, Lindhagen L, Ravn-Fischer A, Szummer K, et al. Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. Eur Heart J. 2020;41:833\u201343.","journal-title":"Eur Heart J"},{"key":"709_CR69","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2021.0716","volume":"325","author":"H Kamran","year":"2021","unstructured":"Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, Khalid U. Oral antiplatelet therapy after acute coronary syndrome: A review. JAMA. 2021;325:1545\u201355.","journal-title":"JAMA"},{"key":"709_CR70","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","volume":"15","author":"JD McFadyen","year":"2018","unstructured":"McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol. 2018;15:181\u201391.","journal-title":"Nat Rev Cardiol"},{"key":"709_CR71","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.2515","volume":"17","author":"SP Jackson","year":"2011","unstructured":"Jackson SP. Arterial thrombosis\u2013insidious, unpredictable and deadly. Nat Med. 2011;17:1423\u201336.","journal-title":"Nat Med"},{"key":"709_CR72","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.drudis.2014.06.005","volume":"19","author":"P Jiang","year":"2014","unstructured":"Jiang P, Jandrot-Perrus M. New advances in treating thrombotic diseases: GPVI as a platelet drug target. Drug Discov Today. 2014;19:1471\u20135.","journal-title":"Drug Discov Today"},{"key":"709_CR73","doi-asserted-by":"publisher","first-page":"100592","DOI":"10.1016\/j.blre.2019.100592","volume":"38","author":"AT Nurden","year":"2019","unstructured":"Nurden AT. Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI. Blood Rev. 2019;38:100592.","journal-title":"Blood Rev"},{"key":"709_CR74","doi-asserted-by":"crossref","unstructured":"Fock E, Pronin N, Rukoyatkina N, Whaley A, Gambaryan S, Whaley A. Thrombin-induced platelet inhibition by 2\u2019,4\u2019-dihydroxychalcone and 2\u2019,4\u2019-dihydroxydihydrochalcone is mediated by inhibition of ROS production and Thromboxane synthase a activity: structure-activity relationship of polyphenol secondary metabolites from Empetrum nigrum. Nat Prod Res 2024:1\u20139.","DOI":"10.1080\/14786419.2024.2334882"},{"key":"709_CR75","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.redox.2015.10.009","volume":"6","author":"N Carrim","year":"2015","unstructured":"Carrim N, Arthur JF, Hamilton JR, Gardiner EE, Andrews RK, Moran N, Berndt MC, Metharom P. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIb\u03b1. Redox Biol. 2015;6:640\u20137.","journal-title":"Redox Biol"},{"key":"709_CR76","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.thromres.2018.09.063","volume":"171","author":"Y Gu","year":"2018","unstructured":"Gu Y, Sheng R, Wu J, Zhou Y, Qin ZH. Reduced nicotinamide adenine dinucleotide phosphate inhibits rat platelet aggregation and p38 phosphorylation. Thromb Res. 2018;171:121\u20139.","journal-title":"Thromb Res"},{"key":"709_CR77","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1124\/jpet.107.122853","volume":"322","author":"MR Marwali","year":"2007","unstructured":"Marwali MR, Hu CP, Mohandas B, Dandapat A, Deonikar P, Chen J, Cawich I, Sawamura T, Kavdia M, Mehta JL. Modulation of ADP-induced platelet activation by aspirin and Pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther. 2007;322:1324\u201332.","journal-title":"J Pharmacol Exp Ther"},{"key":"709_CR78","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","volume":"123","author":"M Ungerer","year":"2011","unstructured":"Ungerer M, Rosport K, Bultmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, Munch G. Novel antiplatelet drug revacept (Dimeric glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation. 2011;123:1891\u20139.","journal-title":"Circulation"},{"key":"709_CR79","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1161\/ATVBAHA.118.312314","volume":"39","author":"C Voors-Pette","year":"2019","unstructured":"Voors-Pette C, Lebozec K, Dogterom P, Jullien L, Billiald P, Ferlan P, Renaud L, Favre-Bulle O, Avenard G, Machacek M, et al. Safety and tolerability, pharmacokinetics, and pharmacodynamics of ACT017, an antiplatelet GPVI (Glycoprotein VI) fab. Arterioscler Thromb Vasc Biol. 2019;39:956\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"709_CR80","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.intimp.2016.10.011","volume":"40","author":"J Li","year":"2016","unstructured":"Li J, Tong D, Liu J, Chen F, Shen Y. Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2. Int Immunopharmacol. 2016;40:524\u20139.","journal-title":"Int Immunopharmacol"},{"key":"709_CR81","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2020.03.031","volume":"153","author":"J Kai","year":"2020","unstructured":"Kai J, Yang X, Wang Z, Wang F, Jia Y, Wang S, Tan S, Chen A, Shao J, Zhang F, et al. Oroxylin a promotes PGC-1alpha\/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Free Radic Biol Med. 2020;153:89\u2013102.","journal-title":"Free Radic Biol Med"},{"key":"709_CR82","doi-asserted-by":"publisher","first-page":"116110","DOI":"10.1016\/j.biopha.2023.116110","volume":"171","author":"T Liu","year":"2024","unstructured":"Liu T, Zhu S, Yang Y, Qin W, Wang Z, Zhao Z, Liu T, Wang X, Duan T, Liu Y, et al. Oroxylin A ameliorates ultraviolet radiation-induced premature skin aging by regulating oxidative stress via the Sirt1 pathway. Biomed Pharmacother. 2024;171:116110.","journal-title":"Biomed Pharmacother"},{"key":"709_CR83","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1182\/blood.V91.2.484","volume":"91","author":"P Pignatelli","year":"1998","unstructured":"Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood. 1998;91:484\u201390.","journal-title":"Blood"},{"key":"709_CR84","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1182\/blood-2005-03-1047","volume":"106","author":"AJ Begonja","year":"2005","unstructured":"Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, Walter U. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO\/cGMP pathway. Blood. 2005;106:2757\u201360.","journal-title":"Blood"},{"key":"709_CR85","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2008.03.021","volume":"45","author":"N Bakdash","year":"2008","unstructured":"Bakdash N, Williams MS. Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med. 2008;45:158\u201366.","journal-title":"Free Radic Biol Med"},{"key":"709_CR86","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cell.2005.05.016","volume":"121","author":"NK Tonks","year":"2005","unstructured":"Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell. 2005;121:667\u201370.","journal-title":"Cell"},{"key":"709_CR87","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1126\/science.1130481","volume":"312","author":"SG Rhee","year":"2006","unstructured":"Rhee SG. Cell signaling. H2O2, a necessary evil for cell signaling. Science. 2006;312:1882\u20133.","journal-title":"Science"},{"key":"709_CR88","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1074\/jbc.M115.644260","volume":"290","author":"JY Jang","year":"2015","unstructured":"Jang JY, Wang SB, Min JH, Chae YH, Baek JY, Yu DY, Chang TS. Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function. J Biol Chem. 2015;290:11432\u201342.","journal-title":"J Biol Chem"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00709-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T14:50:23Z","timestamp":1742309423000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-025-00709-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00709-9","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments using human subjects were performed in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine (2022-051). All animal procedures were approved by the Ethical Committee of Shanghai University of Traditional Chinese Medicine (Approval No. PZSHUTCM2304240008) and conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85\u2009\u2212\u200923, revised 1996).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}